A1LN34.SAB3 São Paulo

Alnylam Pharmaceuticals, Inc.

61.14+1.07%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tier
Alert levelBaseline

Tier and alert level are a summary. Unlock A1LN34.SA to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+2.52%, upReturn · 1w
−11.65%, downReturn · 1m
−15.53%, downReturn · 3m
−49.89%, downReturn · 1y
−53.82%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 47.

RSI (14)47.20Neutral
MACD / signal-1.88 / -2.85, favorable readingAbove signal line
SMA 5067.99, caution readingPrice below
SMA 20086.24, caution readingPrice below
EMA 2061.08, favorable readingPrice above
ADX (14)16.41Rangebound
+DI / −DI40.33 / 41.99−DI leading
ATR (14)1.402.3% of price — typical daily swing
Stochastic %K86.44, flagged readingOverbought zone
Bollinger bands (20)48.74 – 68.42Inside bands
ROC (10)7.94, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking A1LN34.SA reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock A1LN34.SA: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get A1LN34.SA + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock A1LN34.SA